Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from UBS

Tipranks - Tipranks - Thu Feb 5, 1:54AM CST

In a report released on February 2, David Low from UBS maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh. The company’s shares closed today at A$37.06.

Claim 50% Off TipRanks Premium

According to TipRanks, Low is ranked #3525 out of 11984 analysts.

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has an analyst consensus of Strong Buy, with a price target consensus of A$47.69.

See Insiders’ Hot Stocks on TipRanks >>

Based on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of A$1.45 billion and a net profit of A$399.08 million. In comparison, last year the company earned a revenue of A$1.28 billion and had a net profit of A$344.62 million

Read More on AU:RMD:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).